Neonode Swings to Profit on $19.4M Patent Gain, Revenue Declines
Ticker: NEON · Form: 10-Q · Filed: Nov 6, 2025 · CIK: 87050
Sentiment: mixed
Topics: Patent Monetization, Revenue Decline, Net Income Surge, Cash Flow Negative, Technology Licensing, Non-Recurring Gain, Small Cap
Related Tickers: NEON
TL;DR
**Neonode's patent windfall is a one-off lifeline, but don't mistake it for a sustainable turnaround; the core business is still shrinking.**
AI Summary
Neonode Inc. reported a significant turnaround in its financial performance for the three and nine months ended September 30, 2025, primarily driven by a substantial gain from a patent assignment. The company posted a net income of $14.184 million for the three months ended September 30, 2025, compared to a net loss of $1.087 million in the same period of 2024. For the nine months ended September 30, 2025, net income was $10.583 million, a stark improvement from a net loss of $4.866 million in the prior year. This positive shift was largely due to a $19.389 million gain from a patent assignment recognized in the third quarter of 2025, partially offset by a $3.878 million broker fee. Total revenues, however, decreased to $430,000 for the three months ended September 30, 2025, down from $838,000 in 2024, and to $1.542 million for the nine months, down from $2.453 million. Operating expenses remained relatively stable at $2.122 million for the quarter and $7.294 million for the nine months. Cash and cash equivalents decreased from $16.427 million at December 31, 2024, to $11.585 million at September 30, 2025, with operating activities using $4.637 million in cash during the nine-month period.
Why It Matters
This filing reveals a critical, one-time financial boost for Neonode Inc. through a patent assignment, which significantly improved its balance sheet and net income. While the patent gain provides a much-needed liquidity injection, the underlying decline in core revenues from license fees and non-recurring engineering suggests ongoing challenges in its operational business model. For investors, this raises questions about sustainable growth beyond extraordinary events. Competitively, this cash infusion could allow Neonode to invest in R&D or strategic partnerships, potentially shifting its market position, but without a clear path to revenue growth, its long-term viability remains a concern for employees and customers dependent on its technology.
Risk Assessment
Risk Level: medium — The company reported a significant net income of $14.184 million for the quarter, primarily due to a $19.389 million gain from a patent assignment. However, core revenues from license fees and non-recurring engineering declined by 48.7% and 77.6% respectively for the three months ended September 30, 2025, compared to the prior year. This reliance on a one-time event for profitability, coupled with negative cash flow from operations of $4.637 million for the nine months, indicates underlying operational weakness despite the temporary financial boost.
Analyst Insight
Investors should view Neonode's recent profitability with caution, recognizing it stems from a non-recurring patent gain rather than improved operational performance. Focus on the declining core revenues and negative cash flow from operations. Await clear evidence of sustainable revenue growth and positive operational cash flow before considering a long-term investment.
Financial Highlights
- debt To Equity
- 0.22
- revenue
- $430K
- operating Margin
- N/A
- total Assets
- $32.819M
- total Debt
- $6.016M
- net Income
- $14.184M
- eps
- N/A
- gross Margin
- 97.9%
- cash Position
- $11.585M
- revenue Growth
- -48.7%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| License fees | $406K | -44.6% |
| Non-recurring engineering | $24K | -77.4% |
Key Numbers
- $14.184M — Net income for Q3 2025 (Significant increase from a $1.087M net loss in Q3 2024, primarily due to patent gain.)
- $19.389M — Gain from patent assignment (One-time gain recognized in Q3 2025, driving profitability.)
- $430K — Total revenues for Q3 2025 (48.7% decrease from $838K in Q3 2024, indicating core business decline.)
- $3.878M — Broker fee from patent assignment (Expense related to the patent gain, partially offsetting its impact.)
- $11.585M — Cash and cash equivalents as of Sep 30, 2025 (Decrease from $16.427M at Dec 31, 2024, despite the patent gain.)
- $4.637M — Net cash used in operating activities for nine months ended Sep 30, 2025 (Continued negative operational cash flow, highlighting ongoing liquidity challenges.)
- $213.497M — Accumulated deficit as of Sep 30, 2025 (Reduced from $224.080M at Dec 31, 2024, due to the patent gain.)
- 16,782,922 — Common shares outstanding as of Nov 3, 2025 (Stable share count since Q3 2024.)
Key Players & Entities
- Neonode Inc. (company) — registrant of the 10-Q filing
- Seiko Epson (company) — customer accounting for 46.3% of net revenues in Q3 2025
- Hewlett-Packard (company) — customer accounting for 21.5% of net revenues in Q3 2025
- Alps Alpine (company) — customer accounting for 15.0% of net revenues in Q3 2025
- Nasdaq Stock Market LLC (regulator) — exchange where NEON common stock is registered
- SEC (regulator) — Securities and Exchange Commission
FAQ
What caused Neonode Inc.'s significant net income in Q3 2025?
Neonode Inc.'s net income of $14.184 million for the three months ended September 30, 2025, was primarily driven by a $19.389 million gain from a patent assignment. This one-time event significantly offset operating losses and resulted in overall profitability for the quarter.
How did Neonode's core revenues perform in Q3 2025?
Neonode's total revenues decreased to $430,000 for the three months ended September 30, 2025, a 48.7% drop from $838,000 in the same period of 2024. License fees fell from $731,000 to $406,000, and non-recurring engineering revenues decreased from $107,000 to $24,000.
What is Neonode's cash position and cash flow from operations?
As of September 30, 2025, Neonode had $11.585 million in cash and cash equivalents, down from $16.427 million at December 31, 2024. For the nine months ended September 30, 2025, the company used $4.637 million in cash from operating activities, indicating continued operational cash burn.
Who are Neonode's largest customers by revenue?
For the three months ended September 30, 2025, Neonode's largest customers by net revenues were Seiko Epson (46.3%), Hewlett-Packard (21.5%), and Alps Alpine (15.0%). These three customers collectively accounted for 82.8% of net revenues during the quarter.
What is the impact of the patent assignment on Neonode's balance sheet?
The patent assignment resulted in a $19.389 million 'Receivable from patent assignment' as a current asset on the balance sheet as of September 30, 2025. Concurrently, an 'Accrued broker fee from patent assignment' of $3.878 million was recorded as a current liability.
Has Neonode Inc. been profitable historically?
No, Neonode Inc. has incurred significant operating losses and negative cash flows from operations since its inception, with an accumulated deficit of approximately $213.5 million as of September 30, 2025. The recent net income is an exception due to the one-time patent gain.
What are the key risks for Neonode Inc. investors?
Key risks for Neonode Inc. investors include declining core revenues, continued negative cash flow from operations, and heavy reliance on a few major customers. The company's long history of operating losses also poses a significant risk to its long-term financial stability.
How does Neonode's operating income compare year-over-year?
Neonode's operating income dramatically improved to $13.810 million for the three months ended September 30, 2025, compared to an operating loss of $1.225 million in the same period of 2024. This improvement is directly attributable to the $19.389 million gain from the patent assignment.
What is Neonode's strategy for future growth given declining revenues?
The filing does not explicitly detail a new strategy for future growth beyond the patent monetization. While the patent gain provides a cash infusion, the continued decline in license fees and non-recurring engineering revenues suggests that the company needs to articulate a clear strategy for revitalizing its core business or developing new revenue streams.
What is the status of Neonode's deferred tax assets?
Neonode has fully reserved its net deferred tax assets as of September 30, 2025, and December 31, 2024. This indicates management's uncertainty about the realization of these assets in the future, based on the 'more likely than not' criteria of accounting guidance.
Risk Factors
- Dependence on patent assignment gain [high — financial]: The company's significant net income in Q3 2025 was driven by a one-time $19.389 million gain from a patent assignment. This gain is not recurring and masks a substantial decline in core revenue, which fell 48.7% to $430,000 in Q3 2025. The company also incurred a $3.878 million broker fee related to this assignment.
- Declining core revenue [high — financial]: Total revenues decreased to $430,000 for Q3 2025 from $838,000 in Q3 2024, a 48.7% drop. For the nine months ended September 30, 2025, revenues were $1.542 million, down from $2.453 million in the prior year. This indicates a weakening in the company's primary business operations.
- Negative operating cash flow [medium — financial]: Neonode used $4.637 million in cash for operating activities during the nine months ended September 30, 2025. This continued negative cash flow from operations, despite the large patent gain, highlights ongoing liquidity challenges and the need for careful cash management.
- Decreasing cash reserves [medium — financial]: Cash and cash equivalents decreased from $16.427 million at December 31, 2024, to $11.585 million at September 30, 2025. This reduction, coupled with negative operating cash flow, suggests a shrinking liquidity buffer.
- Reliance on R&D and SG&A spending [medium — operational]: Operating expenses remained relatively stable, with Research and Development at $2.843 million and Sales, General & Administrative at $4.451 million for the nine months ended September 30, 2025. While stable, these represent significant ongoing costs that consume cash, especially given the declining revenue.
Industry Context
Neonode operates in the technology sector, specifically focusing on sensor technologies for various applications. The industry is characterized by rapid innovation, intense competition, and the importance of intellectual property. Companies often rely on licensing, partnerships, and product development to drive revenue. The shift towards digital transformation and IoT continues to create opportunities, but also demands significant R&D investment and market adaptation.
Regulatory Implications
As a publicly traded company, Neonode is subject to SEC regulations and reporting requirements, including timely filing of financial statements and disclosures. Any misstatement or failure to disclose material information could lead to regulatory scrutiny and penalties. The company's financial performance and disclosures are critical for maintaining investor confidence and compliance.
What Investors Should Do
- Monitor core revenue trends
- Assess cash burn rate
- Evaluate sustainability of profitability
- Analyze the impact of patent assignment costs
Key Dates
- 2025-09-30: End of Q3 2025 — Reported significant net income driven by patent assignment gain, but core revenue declined substantially.
- 2025-09-30: Balance Sheet Date — Cash and cash equivalents stood at $11.585 million, down from $16.427 million at year-end 2024.
- 2024-09-30: End of Q3 2024 — Reported a net loss of $1.087 million on revenues of $838,000.
- 2024-12-31: End of Fiscal Year 2024 — Cash and cash equivalents were $16.427 million.
Glossary
- Gain from patent assignment
- A one-time profit recognized from the sale or transfer of patent rights. (This was the primary driver of Neonode's net income in Q3 2025, accounting for $19.389 million, but it is not a sustainable source of earnings.)
- Broker fee from patent assignment
- A commission or fee paid to an intermediary for facilitating the patent assignment transaction. (This $3.878 million expense reduced the net benefit of the patent assignment gain.)
- Accumulated deficit
- The cumulative net losses of a company over its lifetime that have not been offset by net income. (Neonode's accumulated deficit decreased to $213.497 million from $224.080 million due to the patent gain, but it remains a substantial negative equity position.)
- Non-recurring engineering
- Revenue generated from specific, one-off engineering projects rather than ongoing product sales or licensing. (This revenue stream saw a significant decline in Q3 2025, contributing to the overall revenue decrease.)
- Contract asset
- Represents the entity's right to consideration in exchange for goods or services that the entity has transferred to a customer when that right is conditional on something other than the passage of time. (This asset decreased from $51K to $0, indicating a change in contractual arrangements or completion of related obligations.)
Year-Over-Year Comparison
Compared to the prior year's comparable periods, Neonode Inc. has shown a dramatic shift in net income, moving from a net loss of $1.087 million in Q3 2024 to a net income of $14.184 million in Q3 2025, largely due to a $19.389 million patent assignment gain. However, this profitability masks a significant decline in core operations, with total revenues falling by 48.7% to $430,000 in Q3 2025. Operating expenses remained relatively stable, but the company's cash position has decreased from $16.427 million at the end of 2024 to $11.585 million as of September 30, 2025, alongside continued negative cash flow from operations.
Filing Stats: 4,831 words · 19 min read · ~16 pages · Grade level 13.9 · Accepted 2025-11-06 09:20:49
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share NEON The Nasdaq Stock Mar
Filing Documents
- neon20250930_10q.htm (10-Q) — 1327KB
- ex_864462.htm (EX-31.1) — 9KB
- ex_864463.htm (EX-31.2) — 9KB
- ex_864464.htm (EX-32) — 8KB
- neon20250930_10qimg001.jpg (GRAPHIC) — 1KB
- 0001437749-25-033478.txt ( ) — 5594KB
- neon-20250930.xsd (EX-101.SCH) — 32KB
- neon-20250930_cal.xml (EX-101.CAL) — 47KB
- neon-20250930_def.xml (EX-101.DEF) — 217KB
- neon-20250930_lab.xml (EX-101.LAB) — 210KB
- neon-20250930_pre.xml (EX-101.PRE) — 242KB
- neon20250930_10q_htm.xml (XML) — 1142KB
FINANCIAL INFORMATION
PART I FINANCIAL INFORMATION 1 Item 1
Financial Statements (Unaudited)
Financial Statements (Unaudited) 1 Unaudited Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024 1 Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2025 and 2024 2 Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2025 and 2024 3 Unaudited Condensed Consolidated Statements of Stockholders ' Equity for the three and nine months ended September 30, 2025 and 2024 4 Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024 5 Notes to Unaudited Condensed Consolidated Financial Statements 6 Item 2 Management ' s Discussion and Analysis of Financial Condition and Results of Operations 14 Item 3
Quantitative and Qualitative Disclosures about Market Risk
Quantitative and Qualitative Disclosures about Market Risk 24 Item 4
Controls and Procedures
Controls and Procedures 24
OTHER INFORMATION
PART II OTHER INFORMATION 25 Item 1
Legal Proceedings
Legal Proceedings 25 Item 1A
Risk Factors
Risk Factors 25 Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 25 Item 3 Defaults Upon Senior Securities 25 Item 4 Mine Safety Disclosures 25 Item 5 Other Information 25 Item 6 Exhibits 25
SIGNATURES
SIGNATURES 26 EXHIBITS i Table of Contents
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
Financial Statements (Unaudited)
Item 1. Financial Statements (Unaudited) NEONODE INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (In thousands, except share and per share amounts) September 30, 2025 December 31, 2024 ASSETS Current assets: Cash and cash equivalents $ 11,585 $ 16,427 Accounts receivable and unbilled revenues, net 649 732 Contract asset - 51 Prepaid expenses and other current assets 529 475 Receivable from patent assignment 19,389 - Current assets of discontinued operations 41 - Total current assets 32,193 17,685 Non-current assets: Property and equipment, net 160 62 Operating lease right-of-use assets, net 466 634 Total non-current assets 626 696 Total assets $ 32,819 $ 18,381 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 525 $ 229 Accrued payroll and employee benefits 909 760 Accrued expenses 248 404 Accrued broker fee from patent assignment 3,878 - Contract liabilities 62 - Current portion of finance lease obligations 12 2 Current portion of operating lease obligations 295 225 Total current liabilities 5,929 1,620 Non-current liabilities: Finance lease obligations, net of current portion 18 - Operating lease obligations, net of current portion 69 319 Total non-current liabilities 87 319 Total liabilities 6,016 1,939 Commitments and contingencies (Note 4) Stockholders' equity: Preferred stock, 1,000,000 shares authorized, with par value of $ 0.001 ; no shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively. - - Common stock, 25,000,000 shares authorized, with par value of $ 0.001 ; 16,782,922 and 16,782,922 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively. 17 17 Additional paid-in capital 240,955 240,955 Accumulated other comprehensive loss ( 672 ) ( 450 ) Accumulated deficit ( 213,497 ) ( 224,080 ) Total stockholders' equity 26,803 16,442 Total liabilities and stockh